retatrutide triple agonist Today, we shared new data from two Phase 3 trials of retatrutide, our investigational agonist. Learn more at our link in bio Triple Agonist Peptides Explained: Retatrutide,

Get GLP-1 Medications through PlushCare PlushCare is for the person who wants access to GLP-1s but would prefer to speak with a doctor without visiting one in person

* Always check with your clinician before starting new products

Tirzepatide activates two receptors

Research shows that these injections may lead to improvements in metabolic health, including: Better blood sugar control Reduced cholesterol levels Lower blood pressure These benefits are particularly significant for individuals with weight-related conditions

Phase 2 data in patients with type 2 diabetes demonstrated HbA1c reductions of up to 2.16% at the 12mg dose after 36 weeks, along with 16.9% body weight reduction

GLP-1 Medications and Weight Loss One of the most promising aspects of GLP-1 medications is their potential to aid in weight loss